Contact
searchSearch
HMP Global

The Road Ahead: Optimizing the Treatment of IBD: Changing Paradigms

AIBD

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Stay in the Know

Rheumatology & Arthritis Newsletter

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

Popular Articles

RHEUMATOLOGY
Christine Peoples, MD, on Telemedicine`s Role in a Long-Term Patient-Provider Relationship
06/10/2019
Christine Peoples, MD, from University of Pittsburgh Medical Center, discusses telemedicine in a rheumatology setting, its impact on care amidst the shortage of rheumatologists, and more.
Christine Peoples, MD, from University of Pittsburgh Medical Center, discusses telemedicine in a rheumatology setting, its impact on care amidst the shortage of rheumatologists, and more.
Christine Peoples, MD, from...
06/10/2019
Rheumatology & Arthritis
FDA Approves First Treatment for Certain Inflammatory Arthritis
03/28/2019
The US Food and Drug Administration has approved Cimzia (certolizumab pegol) injection for the treatment of adults with non-radiographic axial spondyloarthritis with objective signs of inflammation. The approval comes...
The US Food and Drug Administration has approved Cimzia (certolizumab pegol) injection for the treatment of adults with non-radiographic axial spondyloarthritis with objective signs of inflammation. The approval comes...
The US...
03/28/2019
Rheumatology & Arthritis
In RA, Immunosuppressant Can Lower Cardiovascular Event Risk
12/13/2018
Individuals with rheumatoid arthritis (RA) who continuously use methotrexate have a 20% decrease in risk for cardiovascular events, according to a new study.   To reach this conclusion, the researchers analyzed...
Individuals with rheumatoid arthritis (RA) who continuously use methotrexate have a 20% decrease in risk for cardiovascular events, according to a new study.   To reach this conclusion, the researchers analyzed...
...
12/13/2018
Rheumatology & Arthritis
In AS, Anti-TNF-α Therapy Can Restore Microvascular Function
10/02/2018
Anti-tumor necrosis factor-α (Anti-TNF- α) inhibitor therapy can replenish microcirculation function and capillary edema in patients with ankylosing spondylitis (AS), according to recent findings.  The research...
Anti-tumor necrosis factor-α (Anti-TNF- α) inhibitor therapy can replenish microcirculation function and capillary edema in patients with ankylosing spondylitis (AS), according to recent findings.  The research...
...
10/02/2018
Rheumatology & Arthritis
Probenecid vs Allopurinol for CV Risk in Gout Patients
02/27/2018
Probenecid use is associated with a modest decrease in the risk of cardiovascular (CV) events in elderly patients with gout, according to a recent study. For their study, the researchers assessed 38,888 gout patients...
Probenecid use is associated with a modest decrease in the risk of cardiovascular (CV) events in elderly patients with gout, according to a recent study. For their study, the researchers assessed 38,888 gout patients...
...
02/27/2018
Rheumatology & Arthritis

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use